Light assisted activation of platelet-rich plasma for enhanced and controlled release of growth factors: a technology-driven proof-of-concept framework.
6 affiliations
- 1Department of Engineering, University of Sannio, Palazzo Dell' Aquila Bosco Lucarelli, Benevento, Italy.
- 2CeRICT scrl Regional Center Information Communication Technology, Palazzo Ex Poste, Benevento, Italy. [email protected].
- 3CeRICT scrl Regional Center Information Communication Technology, Palazzo Ex Poste, Benevento, Italy.
- 4Medical Service, Taranto, Italy.
- 5CeRICT scrl Regional Center Information Communication Technology, Palazzo Ex Poste, Benevento, Italy. [email protected].
- 6Dipartimento di Patologia Clinica e Anatomia Patologica Centro Diagnostico Italiano, Milano, Italy. [email protected].
Abstract
Background
Platelet-rich plasma (PRP) is widely used in regenerative medicine due to its high content of growth factors and bioactive molecules involved in tissue repair and regeneration. However, the lack of standardized preparation protocols leads to significant variability in clinical outcomes. To address this limitation, photobiomodulation (PBM) has emerged as a promising alternative to conventional chemical activation methods, enabling more controlled PRP stimulation and sustained growth factor release, while avoiding the rapid burst secretion and potential platelet damage induced by thrombin or CaCl₂. In this study, we developed a compact illumination system capable of delivering fluence-controlled irradiation at 660 and 830 nm for ex vivo PRP activation and evaluated its effects using an integrated analytical approach combining ELISA and Raman spectroscopy.Results
The effects of different fluences (10-15 J/cm²) and incubation times (1, 24, 48 and 72 h) were systematically investigated to evaluate dose-response effects on PRP activation. To support real-time, label-free monitoring and facilitate clinical translation, Raman spectroscopy was assessed as a non-destructive analytical tool, with ELISA used for reference validation. Our results show that PBM induces reproducible biochemical changes in PRP, with Raman spectral signatures at 72 h (10 and 15 J/cm²) correlating with ELISA growth factor release.Conclusions
This study demonstrates that controlled light-based stimulation enables tunable PRP activation while preserving platelet structural integrity. Integrating a compact PBM device with portable Raman spectroscopy provides a non-destructive, clinically compatible strategy for both modulating and monitoring PRP activation. This approach establishes a technological framework for standardized, dose-defined PRP photoactivation and supports the development of translational, light-guided regenerative therapies.
Related
- PLATELET-RICH PLASMA FOR ENDOMETRIAL MODULATION IN INFERTILE WOMEN UNDERGOING ASSISTED REPRODUCTIVE TECHNOLOGY: A SCOPING REVIEW
- Retrieval-to-abstraction LLM-assisted literature synthesis: Case demonstrations in digital health technology-enabled randomized controlled trial outcome reporting
- Editorial: Advancing embryo transfer in assisted reproductive technology
- New challenges in in vitro fertilization and assisted reproductive technology: Genetic and epigenetic modifications
- Prediction of chemical miscarriage in assisted reproductive technology pregnancies using machine learning: A developmental study
BibTeX
@article{ucci2026light,
title = {{Light assisted activation of platelet-rich plasma for enhanced and controlled release of growth factors: a technology-driven proof-of-concept framework.}},
author = {Sarassunta Ucci and Valeria Iazzetta and Sara Spaziani and Antonio Iele and Giancarlo Luongo and Saverio Graziano and Eugenio Caradonna and Armando Ricciardi and Marco Pisco and Anna Aliberti and Andrea Cusano},
journal = {Journal of biological engineering},
year = {2026},
month = aug,
doi = {10.1186/s13036-026-00733-x},
url = {https://europepmc.org/article/MED/42968165},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Light assisted activation of platelet-rich plasma for enhanced and controlled release of growth factors: a technology-driven proof-of-concept framework.
AU - Sarassunta Ucci
AU - Valeria Iazzetta
AU - Sara Spaziani
AU - Antonio Iele
AU - Giancarlo Luongo
AU - Saverio Graziano
AU - Eugenio Caradonna
AU - Armando Ricciardi
AU - Marco Pisco
AU - Anna Aliberti
AU - Andrea Cusano
PY - 2026
DA - 2026/08/04
JO - Journal of biological engineering
DO - 10.1186/s13036-026-00733-x
UR - https://europepmc.org/article/MED/42968165
AB - Background Platelet-rich plasma (PRP) is widely used in regenerative medicine due to its high content of growth factors and bioactive molecules involved in tissue repair and regeneration. However, the lack of standardized preparation protocols leads to significant variability in clinical outcomes. To address this limitation, photobiomodulation (PBM) has emerged as a promising alternative to conventional chemical activation methods, enabling more controlled PRP stimulation and sustained growth factor release, while avoiding the rapid burst secretion and potential platelet damage induced by thrombin or CaCl₂. In this study, we developed a compact illumination system capable of delivering fluence-controlled irradiation at 660 and 830 nm for ex vivo PRP activation and evaluated its effects using an integrated analytical approach combining ELISA and Raman spectroscopy.Results The effects of different fluences (10-15 J/cm²) and incubation times (1, 24, 48 and 72 h) were systematically investigated to evaluate dose-response effects on PRP activation. To support real-time, label-free monitoring and facilitate clinical translation, Raman spectroscopy was assessed as a non-destructive analytical tool, with ELISA used for reference validation. Our results show that PBM induces reproducible biochemical changes in PRP, with Raman spectral signatures at 72 h (10 and 15 J/cm²) correlating with ELISA growth factor release.Conclusions This study demonstrates that controlled light-based stimulation enables tunable PRP activation while preserving platelet structural integrity. Integrating a compact PBM device with portable Raman spectroscopy provides a non-destructive, clinically compatible strategy for both modulating and monitoring PRP activation. This approach establishes a technological framework for standardized, dose-defined PRP photoactivation and supports the development of translational, light-guided regenerative therapies.
SN - 1754-1611
ER -